---
title: "Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293754159.md"
description: "Truist Financial analyst David S Macdonald reaffirmed a Hold rating on Quest Diagnostics (DGX) with a $250 price target. While Robert W. Baird also issued a Hold, Barclays maintained a Buy rating on the stock today."
datetime: "2026-07-24T11:56:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293754159.md)
  - [en](https://longbridge.com/en/news/293754159.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293754159.md)
generator: "portal-rs"
---

# Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX)

Truist Financial analyst David S Macdonald maintained a Hold rating on Quest Diagnostics today and set a price target of $250.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

S Macdonald covers the Healthcare sector, focusing on stocks such as Centene, CVS Health, and Molina Healthcare. According to TipRanks, S Macdonald has an average return of 12.4% and a 62.12% success rate on recommended stocks. 

In addition to Truist Financial, Quest Diagnostics also received a Hold from Robert W. Baird’s Eric Coldwell in a report issued today. However, on the same day, Barclays maintained a Buy rating on Quest Diagnostics (NYSE: DGX).

### Related Stocks

- [DGX.US](https://longbridge.com/en/quote/DGX.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)
- [CNC.US](https://longbridge.com/en/quote/CNC.US.md)
- [CVS.US](https://longbridge.com/en/quote/CVS.US.md)
- [MOH.US](https://longbridge.com/en/quote/MOH.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [Jupiter Topco LLC Purchases New Position in Quest Diagnostics Incorporated $DGX](https://longbridge.com/en/news/298006658.md)
- [Quest Diagnostics CEO James E. Davis sells 10,000 shares worth $2.43 million](https://longbridge.com/en/news/297959363.md)
- [Commerce Bank Makes New Investment in Quest Diagnostics Incorporated $DGX](https://longbridge.com/en/news/296754573.md)
- [Quest Diagnostics SVP, General Counsel Michael E. Prevoznik disposes of shares worth $5.52 million](https://longbridge.com/en/news/297559720.md)
- [Quest Holdings 6M FY26 EAT climbs 25.2% to EUR 28 million; sales rise 9.8% to EUR 750 million](https://longbridge.com/en/news/297873843.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**